Evidence map›Paper›PMID 30496323›Full record

ArticlePloS one2018

Metabolomics approach in the investigation of depression biomarkers in pharmacologically induced immune-related depression.

Andreas Baranyi, Andreas Meinitzer, Hans-Bernd Rothenhäusler, Omid Amouzadeh-Ghadikolai, Dirk V Lewinski, Robert J Breitenecker, Markus Herrmann

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Bacterial Metabolites of Human Gut Microbiota Correlating with Depression.International journal of molecular sciences · 2020
    Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Andreas BaranyiDepartment of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.ORCID 0000-0003-2389-1945
Andreas MeinitzerClinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
Hans-Bernd RothenhäuslerDepartment of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Omid Amouzadeh-GhadikolaiLKH Graz Süd-West, Graz, Austria.
Dirk V LewinskiDivision of Cardiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Robert J BreiteneckerInstitute of Innovation Management, Johannes Kepler University, Linz, Austria.
Markus HerrmannClinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
Medical University of Graz · ATGraz University Hospital · ATJohannes Kepler University of Linz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to identify previously unrecognised biological pathways and biomarkers that might expand the inflammatory hypothesis of depression.

methodsBroad metabolomics analyses in plasma samples from 31 chronic hepatitis C-infected patients with and without immune-related depression were carried out using the Absolute IDQ p180 kit-a targeted metabolomics approach of combined direct flow injection and liquid chromatography that measures acylcarnitines, amino acids, biogenic amines, glycerophospholipids, sphingolipids, and sugars.

resultsThe measurements showed that the average concentration of the branched-chain amino acid isoleucine was significantly lower in depressive HCV patients in comparison to non-depressive HCV patients [depression group: Median 51.35 (43.4-60.2 μmol/L) vs. Median 62.10 (38.4-81.7 μmol/L); U = -2.958; p = 0.002]. All other amino acids, acylcarnitines, biogenic amines, glycerophospholipids, sphingolipids, sugars, liver enzymes and thyroid levels showed no statistically significant differences.

conclusionsThe results of the present study suggest that the branched-chain amino acid isoleucine might play a role in the pathophysiology of immune-related major depression, which expands existing knowledge about inflammatory hypothesis of depression.

Indexed as

AdultAntiviral AgentsBiomarkersDepressionFemaleHepatitis CHumansInflammationInterferon-alphaIsoleucineMaleMetabolomicsMiddle AgedAntiviral AgentsBiomarkersInterferon-alphaIsoleucine

Identifiers

PMID30496323
PMCPMC6264814
OpenAlexW2902974612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.